RBA Wealth Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
Other funds holding MDT
RBA Wealth Management's MDT Position: Q2 2026 in Review
RBA Wealth Management reduced its Medtronic (MDT) stake by 2.1% in Q2 2026, selling an estimated $92.6K and leaving 53,380 shares worth $4.18M. The position accounts for 1.53% of the portfolio, ranked #36.
RBA Wealth Management first reported a position in MDT in Q1 2019 and has held it in 28 quarters since. The position peaked at $5.24M in Q4 2025. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.
- RBA Wealth Management held 53,380 shares of Medtronic worth $4.18M as of Q2 2026.
- RBA Wealth Management sold 1,148 Medtronic shares in Q2 2026, an estimated $92.6K.
- Medtronic made up 1.53% of RBA Wealth Management's portfolio in Q2 2026, its #36 holding.
- RBA Wealth Management first reported a position in Medtronic in Q1 2019 and has held it in 28 quarters since.
- RBA Wealth Management's Medtronic position peaked at $5.24M in Q4 2025.
- 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.
Based on RBA Wealth Management's 13F filing for Q2 2026, filed 23 Jul 2026.